{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T06:06:52Z","timestamp":1699596412988},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12013-023-01149-w","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:01:35Z","timestamp":1689847295000},"page":"533-542","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy"],"prefix":"10.1007","volume":"81","author":[{"given":"Carlos Eduardo Diaz","family":"Jacques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilian","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciele Fatima","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina F. Moura","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Regla","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"1149_CR1","volume-title":"Mucopolysaccharidoses update","author":"S Tomatsu","year":"2018","unstructured":"Tomatsu, S., Lavery, C., Giugliani, R., Harmatz, P., Scarpa, M., Wegrzyn, G., & Orii, T. (2018). Mucopolysaccharidoses update. Nova Science Publishers"},{"key":"1149_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-72","author":"M Scarpa","year":"2011","unstructured":"Scarpa, M., Alm\u00e1ssy, Z., Beck, M., & Bodamer, O., et al. (2011). Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet Journal of Rare Diseases. https:\/\/doi.org\/10.1186\/1750-1172-6-72","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"1149_CR3","doi-asserted-by":"publisher","unstructured":"Jones, S. A., Parini, R., Harmatz, P., Giugliani, R., Fang, J., & Mendelsohn, N. J. (2013). The effect of idursulfase on growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS). Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.001","DOI":"10.1016\/j.ymgme.2013.03.001"},{"key":"1149_CR4","unstructured":"Neufeld, E. F., & Muenzer, J. (2001). The mucopolysaccharidoses. In: C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle (Eds.), The metabolic and molecular bases of inherited disease (8th ed., pp. 3421\u20133452). McGraw-Hill Inc."},{"key":"1149_CR5","doi-asserted-by":"publisher","unstructured":"Stapleton, M., Kubaski, F., Mason, R. W., Yabe, H., Suzuki, Y., Orii, K. E., Orii, T., & Tomatsu, S. (2017). Presentation and treatments for Mucopolysaccharidosis type II (MPS II; Hunter Syndrome). Expert Opinion on Orphan Drugs. https:\/\/doi.org\/10.1080\/21678707.2017.1296761","DOI":"10.1080\/21678707.2017.1296761"},{"key":"1149_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.08.003","author":"BW Bigger","year":"2018","unstructured":"Bigger, B. W., Begley, D. J., Virgintino, D., & Pshezhetsky, A. V. (2018). Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2018.08.003","journal-title":"Molecular Genetics and Metabolism"},{"key":"1149_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269782.90107.fe","author":"L Vedolin","year":"2007","unstructured":"Vedolin, L., Schwartz, I. V., Komlos, M., Schuch, A., Azevedo, A. C., Vieira, T., Maeda, F. K., Marques da Silva, A. M., & Giugliani, R. (2007a). Brain MRI in mucopolysaccharidosis: Effect of aging and correlation with biochemical findings. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000269782.90107.fe","journal-title":"Neurology."},{"issue":"1","key":"1149_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jmd2.12212","volume":"60","author":"R Reichert","year":"2021","unstructured":"Reichert, R., P\u00e9rez, J. A., Dalla-Corte, A., Vairo, F. P. E., de Souza, C. F. M., Giugliani, R., Isolan, G. R., & Stefani, M. A. (2021). Magnetic resonance imaging findings of the posterior fossa in 47 patients with mucopolysaccharidoses: A cross-sectional analysis. JIMD Reports, 60(1), 32\u201341. https:\/\/doi.org\/10.1002\/jmd2.12212","journal-title":"JIMD Reports"},{"issue":"1\u20132","key":"1149_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ymgme.2020.07.005","volume":"131","author":"PE Wikman-Jorgensen","year":"2020","unstructured":"Wikman-Jorgensen, P. E., L\u00f3pez Amor\u00f3s, A., Peris Garc\u00eda, J., Esteve Atienzar, P. J., Ca\u00f1izares Navarro, R., Asensio Tom\u00e1s, M. L., Segu\u00ed Ripoll, J. M., Bonet, D., Esteban-Giner, M. J., Robert, J., & Giner-Galva\u00f1, V. (2020). Enzyme replacement therapy for the treatment of Hunter disease: A systematic review with narrative synthesis and meta-analysis. Molecular Genetics and Metabolism, 131(1\u20132), 206\u2013210. https:\/\/doi.org\/10.1016\/j.ymgme.2020.07.005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"8","key":"1149_CR10","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00109-022-02221-3","volume":"100","author":"F Maccari","year":"2022","unstructured":"Maccari, F., Rigon, L., Mantovani, V., Galeotti, F., Salvalaio, M., D'Avanzo, F., Zanetti, A., Capitani, F., Gabrielli, O., Tomanin, R., & Volpi, N. (2022). Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy. Journal of Molecular Medicine, 100(8), 1169\u20131179. https:\/\/doi.org\/10.1007\/s00109-022-02221-3","journal-title":"Journal of Molecular Medicine"},{"key":"1149_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.30","author":"LA Bradley","year":"2017","unstructured":"Bradley, L. A., Haddow, H. R. M., & Palomaki, G. E. (2017). Treatment of mucopolysaccharidosis type II (Hunter syndrome): Results from a systematic evidence review. Genetics in Medicine. https:\/\/doi.org\/10.1038\/gim.2017.30","journal-title":"Genetics in Medicine"},{"key":"1149_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/164_2019_263","author":"FB Lagler","year":"2019","unstructured":"Lagler, F. B.(2019). Current and emerging therapies for mucopolysaccharidoses. Handbook of Experimental Pharmacology. https:\/\/doi.org\/10.1007\/164_2019_263","journal-title":"Handbook of Experimental Pharmacology"},{"key":"1149_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.02.016","author":"L Filippon","year":"2011","unstructured":"Filippon, L., Vanzin, C. S., Biancini, G. B., Pereira, I. N., Manfredini, V., Sitta, A., Peralba Mdo, C., Schwartz, I. V., Giugliani, R., & Vargas, C. R. (2011). Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2011.02.016","journal-title":"Molecular Genetics and Metabolism"},{"key":"1149_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/21675511.2015.1049793","author":"AV Pshezhetsky","year":"2015","unstructured":"Pshezhetsky, A. V. (2015). Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C. Rare Diseases. https:\/\/doi.org\/10.1080\/21675511.2015.1049793","journal-title":"Rare Diseases"},{"key":"1149_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.05.021","author":"CE Jacques","year":"2016","unstructured":"Jacques, C. E., Donida, B., Mescka, C. P., Rodrigues, D. G., Marchetti, D. P., Bitencourt, F. H., Burin, M. G., de Souza, C. F., Giugliani, R., & Vargas, C. R. (2016). Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: Effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation. Biochimica et Biophysica Acta. https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.021","journal-title":"Biochimica et Biophysica Acta"},{"key":"1149_CR16","doi-asserted-by":"publisher","unstructured":"Holley, R. J., Deligny, A., Wei, W., Watson, H. A., Ni\u00f1onuevo, M. R., Dag\u00e4lv, A., Leary, J. A., Bigger, B. W., Kjell\u00e9n, L., & Merry, C. L. (2011). Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking \u03b1-l-iduronidase. Journal of Biological Chemistry, https:\/\/doi.org\/10.1074\/jbc.M111.287474","DOI":"10.1074\/jbc.M111.287474"},{"key":"1149_CR17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.599944","author":"HA Watson","year":"2014","unstructured":"Watson, H. A., Holley, R. J., Langford-Smith, K. J., Wilkinson, F. L., van Kuppevelt, T. H., Wynn, R. F., Wraith, J. E., Merry, C. L., & Bigger, B. W. (2014). Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I. Journal of Biological Chemistry. https:\/\/doi.org\/10.1074\/jbc.M114.599944","journal-title":"Journal of Biological Chemistry"},{"key":"1149_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.03.071","author":"GR Villani","year":"2009","unstructured":"Villani, G. R., Di Domenico, C., Musella, A., Cecere, F., Di Napoli, D., & Di Natale, P. (2009). Mucopolysaccharidosis IIIB: Oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. Brain Research. https:\/\/doi.org\/10.1016\/j.brainres.2009.03.071","journal-title":"Brain Research"},{"key":"1149_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-008-9335-5","author":"GK Reolon","year":"2009","unstructured":"Reolon, G. K., Reinke, A., de Oliveira, M. R., Braga, L. M., Camassola, M., Andrades, M. E., Moreira, J. C., Nardi, N. B., Roesler, R., & Dal-Pizzol, F. (2009). Alterations in oxidative markers in the cerebellum and peripheral organs in MPS I mice. Cellular and Molecular Neurobiology. https:\/\/doi.org\/10.1007\/s10571-008-9335-5","journal-title":"Cellular and Molecular Neurobiology"},{"key":"1149_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-013-9613-3","author":"LD Archer","year":"2014","unstructured":"Archer, L. D., Langford-Smith, K. J., Bigger, B. W., & Fildes, J. E. (2014). Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity. Journal of Inherited Metabolic Disease. https:\/\/doi.org\/10.1007\/s10545-013-9613-3","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1149_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/metabo4030655","author":"S Tomatsu","year":"2014","unstructured":"Tomatsu, S., Shimada, T., Mason, R. W., Monta\u00f1o, A. M., Kelly, J., LaMarr, W. A., Kubaski, F. 7, Giugliani, R., Guha, A., Yasuda, E., Mackenzie, W., Yamaguchi, S., Suzuki, Y., & Orii, T. (2014). Establishment of glycosaminoglycan assays for mucopolysaccharidoses. Metabolites. https:\/\/doi.org\/10.3390\/metabo4030655","journal-title":"Metabolites"},{"key":"1149_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9254-8","author":"KJ Langford-Smith","year":"2011","unstructured":"Langford-Smith, K. J., Mercer, J., Petty, J., Tylee, K., Church, H., Roberts, J., Moss, G., Jones, S., Wynn, R., Wraith, J. E., & Bigger, B. W. (2011). Heparin cofactor II-thrombin complex and dermatan sulphate: Chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. Journal of Inherited Metabolic Disease. https:\/\/doi.org\/10.1007\/s10545-010-9254-8","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1149_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36470","author":"V Brochard","year":"2009","unstructured":"Brochard, V., Combadi\u00e8re, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J. M., Duyckaerts, C., Flavell, R. A., Hirsch, E. C., & Hunot, S. (2009). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"Journal of Clinical Investigation"},{"key":"1149_CR24","doi-asserted-by":"publisher","DOI":"10.3109\/15622971003797241","author":"OV Forlenza","year":"2010","unstructured":"Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Ojopi, E. B., Talib, L. L., Mendon\u00e7a, V. A., Izzo, G., & Gattaz, W. F. (2010). Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World Journal of Biological Psychiatry. https:\/\/doi.org\/10.3109\/15622971003797241","journal-title":"World Journal of Biological Psychiatry"},{"key":"1149_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2011.12.014","author":"I Tasset","year":"2012","unstructured":"Tasset, I., S\u00e1nchez-L\u00f3pez, F., Ag\u00fcera, E., Fern\u00e1ndez-Bola\u00f1os, R., S\u00e1nchez, F. M., Cruz-Guerrero, A., Gasc\u00f3n-Luna, F., & T\u00fanez, I. (2012). NGF and nitrosative stress in patients with Huntington\u2019s disease. Journal of the Neurological Sciences. https:\/\/doi.org\/10.1016\/j.jns.2011.12.014","journal-title":"Journal of the Neurological Sciences"},{"key":"1149_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0116-8","author":"G Scaini","year":"2017","unstructured":"Scaini, G., Tonon, T., de Souza, C. F. M., Schuk, P. F., Ferreira, G. C., Neto, J. S., Amorin, T., Schwartz, I. V. D., & Streck, E. L. (2017). Serum markers of neurodegeneration in maple syrup urine disease. Molecular Neurobiology. https:\/\/doi.org\/10.1007\/s12035-016-0116-8","journal-title":"Molecular Neurobiology"},{"key":"1149_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517748843","author":"Y Huang","year":"2018","unstructured":"Huang, Y., Yun, W., Zhang, M., Luo, W., & Zhou, X. (2018). Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson\u2019s disease or essential tremor. Journal of International Medical Research. https:\/\/doi.org\/10.1177\/0300060517748843","journal-title":"Journal of International Medical Research"},{"key":"1149_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2016.11.006","author":"M Kojima","year":"2017","unstructured":"Kojima, M., & Mizui, T. (2017). BDNF propeptide: A novel modulator of synaptic plasticity. Vitamins and Hormones. https:\/\/doi.org\/10.1016\/bs.vh.2016.11.006","journal-title":"Vitamins and Hormones"},{"key":"1149_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03135.x","author":"S Peng","year":"2005","unstructured":"Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005). Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer\u2019s disease. Journal of Neurochemistry. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03135.x","journal-title":"Journal of Neurochemistry"},{"key":"1149_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-011-8154-x","author":"BS Diniz","year":"2011","unstructured":"Diniz, B. S., & Teixeira, A. L. (2011). Brain-derived neurotrophic factor and Alzheimer\u2019s disease: Physiopathology and beyond. Neuromolecular Medicine. https:\/\/doi.org\/10.1007\/s12017-011-8154-x","journal-title":"Neuromolecular Medicine"},{"key":"1149_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-328x(97)00125-3","author":"B Connor","year":"1997","unstructured":"Connor, B., Young, D., Yan, Q., Faull, R. L., Synek, B., & Dragunow, M. (1997). Brain-derived neurotrophic factor is reduced in Alzheimer\u2019s disease. Brain Research and Molecular Brain Research. https:\/\/doi.org\/10.1016\/s0169-328x(97)00125-3","journal-title":"Brain Research and Molecular Brain Research"},{"key":"1149_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-328x(00)00023-1","author":"RM Holsinger","year":"2000","unstructured":"Holsinger, R. M., Schnarr, J., Henry, P., Castelo, V. T., & Fahnestock, M. (2000). Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: Decreased levels in Alzheimer\u2019s disease. Brain Research and Molecular Brain Research. https:\/\/doi.org\/10.1016\/s0169-328x(00)00023-1","journal-title":"Brain Research and Molecular Brain Research"},{"key":"1149_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00363","author":"M Miranda","year":"2019","unstructured":"Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019). Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain. Frontiers in Cellular Neuroscience. https:\/\/doi.org\/10.3389\/fncel.2019.00363","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"1149_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2007.10.050","author":"JG Hu","year":"2008","unstructured":"Hu, J. G., Fu, S. L., Wang, Y. X., Li, Y., Jiang, X. Y., Wang, X. F., Qiu, M. S., Lu, P. H., & Xu, X. M. (2008). Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.10.050","journal-title":"Neuroscience"},{"key":"1149_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03476.x","author":"MH Harirchian","year":"2012","unstructured":"Harirchian, M. H., Tekieh, A. H., Modabbernia, A., Aghamollaii, V., Tafakhori, A., Ghaffarpour, M., Sahraian, M. A., Naji, M., & Yazdankhah, M. (2012). Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: A case-control study. European Journal of Neurology. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03476.x","journal-title":"European Journal of Neurology"},{"key":"1149_CR36","first-page":"1151","volume":"152","author":"K Roberg","year":"1998","unstructured":"Roberg, K., & Ollinger, K. (1998). Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. The American Journal of Pathology, 152, 1151\u20131156","journal-title":"The American Journal of Pathology"},{"key":"1149_CR37","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-04-0301","author":"L Emert-Sedlak","year":"2005","unstructured":"Emert-Sedlak, L., Shangary, S., Rabinovitz, A., Miranda, M. B., Delach, S. M., & Johnson, D. E. (2005). Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Molecular Cancer Therapeutics. https:\/\/doi.org\/10.1158\/1535-7163.MCT-04-0301","journal-title":"Molecular Cancer Therapeutics"},{"key":"1149_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1975.tb02342.x","author":"RT Dean","year":"1975","unstructured":"Dean, R. T. (1975). Lysosomal enzymes as agents of turnover of soluble cytoplasmic proteins. European Journal of Biochemistry. https:\/\/doi.org\/10.1111\/j.1432-1033.1975.tb02342.x","journal-title":"European Journal of Biochemistry"},{"key":"1149_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.04.020","author":"S Gnanapavan","year":"2010","unstructured":"Gnanapavan, S., Grant, D., Illes-Toth, E., Lakdawala, N., Keir, G., & Giovannoni, G. (2010). Neural cell adhesion molecule\u2013description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders. Journal of Neuroimmunology. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.04.020","journal-title":"Journal of Neuroimmunology"},{"key":"1149_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/bf01694535","author":"OS J\u00f8rgensen","year":"1995","unstructured":"J\u00f8rgensen, O. S. (1995). Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochemical Research. https:\/\/doi.org\/10.1007\/bf01694535","journal-title":"Neurochemical Research"},{"key":"1149_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.11.014","author":"L Todaro","year":"2004","unstructured":"Todaro, L., Puricelli, L., Gioseffi, H., Guadalupe Pallotta, M., Lastiri, J., Bal de Kier Joff\u00e9, E., Varela, M., & Sacerdote de Lustig, E. (2004). Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type. Neurobiology of Disease. https:\/\/doi.org\/10.1016\/j.nbd.2003.11.014","journal-title":"Neurobiology of Disease"},{"key":"1149_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/38.6.803","author":"JG de Jong","year":"1992","unstructured":"de Jong, J. G., Wevers, R. A., & Liebrand-van Sambeek, R. (1992). Measuring urinary glycosaminoglycans in the presence of protein: An improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clinical Chemistry. https:\/\/doi.org\/10.1093\/clinchem\/38.6.803","journal-title":"Clinical Chemistry"},{"key":"1149_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00211.x","author":"ME Haskins","year":"2007","unstructured":"Haskins, M. E. (2007). Animal models for mucopolysaccharidosis disorders and their clinical relevance. Acta Paediatrica. https:\/\/doi.org\/10.1111\/j.1651-2227.2007.00211.x","journal-title":"Acta Paediatrica"},{"key":"1149_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21134","author":"GR Villani","year":"2007","unstructured":"Villani, G. R., Gargiulo, N., Faraonio, R., Castaldo, S., Gonzalez, Y., Reyero, E., & Di Natale, P. (2007). Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. Journal of Neuroscience Research. https:\/\/doi.org\/10.1002\/jnr.21134","journal-title":"Journal of Neuroscience Research"},{"key":"1149_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.430","author":"E Fusar Poli","year":"2013","unstructured":"Fusar Poli, E., Zalfa, C., D\u2019Avanzo, F., Tomanin, R., Carlessi, L., Bossi, M., Nodari, L. R., Binda, E., Marmiroli, P., Scarpa, M., Delia, D., Vescovi, A. L., & De Filippis, L. (2013). Murine neural stem cells model Hunter disease in vitro: Glial cell-mediated neurodegeneration as a possible mechanism involved. Cell Death and Disease. https:\/\/doi.org\/10.1038\/cddis.2013.430","journal-title":"Cell Death and Disease"},{"key":"1149_CR46","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2832","author":"DI Zafeiriou","year":"2013","unstructured":"Zafeiriou, D. I., & Batzios, S. P. (2013). Brain and spinal MR imaging findings in mucopolysaccharidoses: A review. American Journal of Neuroradiology. https:\/\/doi.org\/10.3174\/ajnr.A2832","journal-title":"American Journal of Neuroradiology"},{"key":"1149_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0325-3","author":"K Hamano","year":"2008","unstructured":"Hamano, K., Hayashi, M., Shioda, K., Fukatsu, R., & Mizutani, S. (2008). Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: Analysis of human brain tissue. Acta Neuropathologica. https:\/\/doi.org\/10.1007\/s00401-007-0325-3","journal-title":"Acta Neuropathologica"},{"key":"1149_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035787","author":"FL Wilkinson","year":"2012","unstructured":"Wilkinson, F. L., Holley, R. J., Langford-Smith, K. J., Badrinath, S., Liao, A., Langford-Smith, A., Cooper, J. D., Jones, S. A., Wraith, J. E., Wynn, R. F., Merry, C. L., & Bigger, B. W. (2012). Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0035787","journal-title":"PLoS ONE"},{"key":"1149_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020396","author":"GM Viana","year":"2020","unstructured":"Viana, G. M., Priestman, D. A., Platt, F. M., Khan, S., Tomatsu, S., & Pshezhetsky, A. V. (2020). Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm9020396","journal-title":"Journal of Clinical Medicine"},{"key":"1149_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912937107","author":"CM Simonaro","year":"2010","unstructured":"Simonaro, C. M., Ge, Y., Eliyahu, E., He, X., Jepsen, K. J., & Schuchman, E. H. (2010). Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses. Proceedings of the National Academy Sciences of the United States of America. https:\/\/doi.org\/10.1073\/pnas.0912937107","journal-title":"Proceedings of the National Academy Sciences of the United States of America"},{"key":"1149_CR51","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0143fje","author":"R Katoh-Semba","year":"2002","unstructured":"Katoh-Semba, R., Asano, T., Ueda, H., Morishita, R., Takeuchi, I. K., Inaguma, Y., & Kato, K. (2002). Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. The FASEB Journal. https:\/\/doi.org\/10.1096\/fj.02-0143fje","journal-title":"The FASEB Journal"},{"key":"1149_CR52","doi-asserted-by":"publisher","DOI":"10.2174\/1874467211003010012","author":"KK Cowansage","year":"2010","unstructured":"Cowansage, K. K., LeDoux, J. E., & Monfils, M. H. (2010). Brain-derived neurotrophic factor: A dynamic gatekeeper of neural plasticity. Current Molecular Pharmacology. https:\/\/doi.org\/10.2174\/1874467211003010012","journal-title":"Current Molecular Pharmacology"},{"key":"1149_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.54","author":"C Zuccato","year":"2009","unstructured":"Zuccato, C., & Cattaneo, E. (2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology. https:\/\/doi.org\/10.1038\/nrneurol.2009.54","journal-title":"Nature Reviews Neurology"},{"key":"1149_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022966","author":"C Zuccato","year":"2011","unstructured":"Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E. J., Sassone, J., Ciammola, A., Bachoud-L\u00e8vi, A. C., Tabrizi, S. J., Di Donato, S., & Cattaneo, E. (2011). Brain-derived neurotrophic factor in patients with Huntington\u2019s disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0022966","journal-title":"PLoS ONE"},{"key":"1149_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030545","author":"SD Chen","year":"2017","unstructured":"Chen, S. D., Wu, C. L., Hwang, W. C., & Yang, D. I. (2017). More insight into BDNF against neurodegeneration: Anti-apoptosis, anti-oxidation, and suppression of autophagy. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms18030545","journal-title":"International Journal of Molecular Sciences"},{"key":"1149_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.05.023","author":"Y Wang","year":"2016","unstructured":"Wang, Y., Liu, H., Zhang, B. S., Soares, J. C., & Zhang, X. Y. (2016). Low BDNF is associated with cognitive impairments in patients with Parkinson\u2019s disease. Parkinsonism & Related Disorders. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.05.023","journal-title":"Parkinsonism & Related Disorders"},{"key":"1149_CR57","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.677","author":"EJ Huang","year":"2001","unstructured":"Huang, E. J., & Reichardt, L. F. (2001). Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annual Review of Neuroscience"},{"key":"1149_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00596-i","author":"Y Yoshimoto","year":"1995","unstructured":"Yoshimoto, Y., Lin, Q., Collier, T. J., Frim, D. M., Breakefield, X. O., & Bohn, M. C. (1995). Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson\u2019s disease. Brain Research. https:\/\/doi.org\/10.1016\/0006-8993(95)00596-i","journal-title":"Brain Research"},{"key":"1149_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.05.072","author":"M Sun","year":"2005","unstructured":"Sun, M., Kong, L., Wang, X., Lu, X. G., Gao, Q., & Geller, A. I. (2005). Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson\u2019s disease. Brain Research. https:\/\/doi.org\/10.1016\/j.brainres.2005.05.072","journal-title":"Brain Research"},{"key":"1149_CR60","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7483","author":"DW Howells","year":"2000","unstructured":"Howells, D. W., Porritt, M. J., Wong, J. Y., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000). Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Experimental Neurology. https:\/\/doi.org\/10.1006\/exnr.2000.7483","journal-title":"Experimental Neurology"},{"key":"1149_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2006.41","author":"EY Kim","year":"2006","unstructured":"Kim, E. Y., Hong, Y. B., Go, S. H., Lee, B., & Jung, S. C. (2006). Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease. Experimental & Molecular Medicine. https:\/\/doi.org\/10.1038\/emm.2006.41","journal-title":"Experimental & Molecular Medicine"},{"key":"1149_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.11.014","author":"AS de Mello","year":"2017","unstructured":"de Mello, A. S., da Silva, I. R., Reinaldo, G. P., Dorneles, G. P., C\u00e9, J., Lago, P. D., Peres, A., Elsner, V. R., & Coelho, J. C. (2017). The modulation of inflammatory parameters, brain-derived neurotrophic factor levels and global histone H4 acetylation status in peripheral blood of patients with Gaucher disease type 1. Clinical Biochemistry. https:\/\/doi.org\/10.1016\/j.clinbiochem.2016.11.014","journal-title":"Clinical Biochemistry"},{"key":"1149_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.09.001","author":"J Muenzer","year":"2007","unstructured":"Muenzer, J., Gucsavas-Calikoglu, M., McCandless, S. E., Schuetz, T. J., & Kimura, A. (2007). A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2006.09.001","journal-title":"Molecular Genetics and Metabolism"},{"key":"1149_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3366","author":"AH Nagahara","year":"2011","unstructured":"Nagahara, A. H., & Tuszynski, M. H. (2011). Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nature Reviews Drug Discovery. https:\/\/doi.org\/10.1038\/nrd3366","journal-title":"Nature Reviews Drug Discovery"},{"key":"1149_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3505","author":"B Lu","year":"2013","unstructured":"Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013). BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature Reviews Neuroscience. https:\/\/doi.org\/10.1038\/nrn3505","journal-title":"Nature Reviews Neuroscience"},{"key":"1149_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031170","author":"E Palasz","year":"2020","unstructured":"Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020). BDNF as a promising therapeutic agent in Parkinson\u2019s disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21031170","journal-title":"International Journal of Molecular Sciences"},{"key":"1149_CR67","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.2.871","author":"N Baumann","year":"2001","unstructured":"Baumann, N., & Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.871","journal-title":"Physiological Reviews"},{"key":"1149_CR68","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181587d46","author":"AC Vana","year":"2007","unstructured":"Vana, A. C., Flint, N. C., Harwood, N. E., Le, T. Q., Fruttiger, M., & Armstrong, R. C. (2007). Platelet-derived growth factor promotes repair of chronically demyelinated white matter. Journal of Neuropathology & Experimental Neurology. https:\/\/doi.org\/10.1097\/NEN.0b013e3181587d46","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"1149_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9582-y","author":"D Klee","year":"2013","unstructured":"Klee, D., Thimm, E., Wittsack, H. J., Schubert, D., Primke, R., Pentang, G., Schaper, J., M\u00f6dder, U., Antoch, A., Wendel, U., & Cohnen, M. (2013). Structural white matter changes in adolescents and young adults with maple syrup urine disease. Journal of Inherited Metabolic Disease. https:\/\/doi.org\/10.1007\/s10545-012-9582-y","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1149_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp024","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti, W. J., Lazovic, J., Griffin, K., Skvorak, K. J., Paul, H. S., Homanics, G. E., Bewley, M. C., Cheng, K. C., Lanoue, K. F., & Flanagan, J. M. (2009). Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awp024.","journal-title":"Brain"},{"key":"1149_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2017.09.006","author":"I Nestrasil","year":"2017","unstructured":"Nestrasil, I., & Vedolin, L. (2017). Quantitative neuroimaging in mucopolysaccharidoses clinical trials. Molecular Genetics and Metabolism. https:\/\/doi.org\/10.1016\/j.ymgme.2017.09.006","journal-title":"Molecular Genetics and Metabolism"},{"key":"1149_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9317-5","author":"R Manara","year":"2011","unstructured":"Manara, R., Priante, E., Grimaldi, M., & Santoro, L., et al. (2011). Brain and spine MRI features of Hunter disease: Frequency, natural evolution and response to therapy. Journal of Inherited Metabolic Disease. https:\/\/doi.org\/10.1007\/s10545-011-9317-5","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"1149_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2012.08.002","author":"S Gnanapavan","year":"2013","unstructured":"Gnanapavan, S., & Giovannoni, G. (2013). Neural cell adhesion molecules in brain plasticity and disease. Multiple Sclerosis and Related Disorders. https:\/\/doi.org\/10.1016\/j.msard.2012.08.002","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"1149_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.11.013","author":"H Strekalova","year":"2006","unstructured":"Strekalova, H., Buhmann, C., Kleene, R., Eggers, C., Saffell, J., Hemperly, J., Weiller, C., M\u00fcller-Thomsen, T., & Schachner, M. (2006). Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes. Neurobiology of Aging. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.11.013","journal-title":"Neurobiology of Aging"},{"key":"1149_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(83)90189-2","author":"PS S\u00f8rensen","year":"1983","unstructured":"S\u00f8rensen, P. S., Gjerris, F., Ibsen, S., & Bock, E. (1983). Low cerebrospinal fluid concentration of brain-specific protein D2 in patients with normal pressure hydrocephalus. Journal of the Neurological Sciences. https:\/\/doi.org\/10.1016\/0022-510x(83)90189-2","journal-title":"Journal of the Neurological Sciences"},{"key":"1149_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490330406","author":"SG Kallapur","year":"1992","unstructured":"Kallapur, S. G., & Akeson, R. A. (1992). The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans. Journal of Neuroscience Research. https:\/\/doi.org\/10.1002\/jnr.490330406","journal-title":"Journal of Neuroscience Research"},{"key":"1149_CR77","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01516.x","author":"L Vutskits","year":"2001","unstructured":"Vutskits, L., Djebbara-Hannas, Z., Zhang, H., Paccaud, J. P., Durbec, P., Rougon, G., Muller, D., & Kiss, J. Z. (2001). PSA-NCAM modulates BDNF-dependent survival and differentiation of cortical neurons. European Journal of Neuroscience. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01516.x","journal-title":"European Journal of Neuroscience"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-023-01149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-023-01149-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-023-01149-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:13:32Z","timestamp":1693314812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-023-01149-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1007\/s12013-023-01149-w","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"23 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R.G. received speaker honoraria, travel grants, educational grants and\/or investigator fees from Actelion, Amicus, Armagen, BioMarin, Inventiva, JCR Pharmaceuticals, Lysogene, RegenxBio, Sangamo, Sanofi-Genzyme, Takeda, Sobi and Ultragenyx. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}